The Cooper Companies, Inc. · NASDAQ:COO

The Cooper Companies — Cooper Companies — Merger or Acquisition (July 2004)

11 slides from The Cooper Companies's merger presentation, Jul 30, 2004

  1. Slide 1: Acquisition of Ocular Sciences, Inc.

    NYSE: COO Acquisition of Ocular Sciences, Inc.

  2. Slide 2: Forward Looking Statements

    FORWARD LOOKING STATEMENTS This presentation contains forward-looking projections of Cooper’s results. Actual results could differ materially from these projections. Additional information concerning factors that could cause material differences can be found in Cooper’s periodic filings with the Sec

  3. Slide 3: Complementary Strategic Fit: Revenue - Product Lines and Geography

    COMPLEMENTRY STRATEGIC FIT REVENUE Product lines OCLR: disposable spheres; daily disposables CVI: specialty lenses Geography OCLR: Japan; Europe (GER) CVI: North America; Europe

  4. Slide 4: Complementary Strategic Fit: Revenue - Customers

    COMPLEMENTARY STRATEGIC FIT REVENUE Customers OCLR: retail optometric chains CVI: professional eye care

  5. Slide 5: Complementary Strategic Fit: Gross Profit

    COMPLEMENTARY STRATEGIC FIT GROSS PROFIT Manufacturing efficiencies OCLR: GenII CVI: CooperSync

  6. Slide 6: Complementary Strategic Fit: Expense Synergies

    COMPLEMENTARY STRATEGIC FIT EXPENSE SYNERGIES SG&A duplication R&D overlap

  7. Slide 7: Market Trends

    MARKET TRENDS ($’s Billions) ‘03 ‘08 CGR Americas $1.6 (46%) $2.4 (44%) +8 Europe $.8 (23%) $1.1 (22%) +6 Asia/Pacific $1.0 (29%) $1.8 (30%) +12 Other .1 (2%) .2 (4%) +15 Total $3.5 (100%) $5.4 (100%) +9 CooperVision $35 (10%) $1.3 (25%) +13

  8. Slide 8: Guidance

    GUIDANCE (Revenue in $’s millions) 2005 2006 2007 COO $930-$943 $1042-$1050 $1165-$1180 CVI $815-$825 $915-$920 $1025-$1035 CSI $115-$118 $127-$130 $140-$145 EPS* $3.25-$3.35 $4.20-$4.30 $5.00-$5.10 ETR 21% 20% 20% * Excludes non-recurring items

  9. Slide 9: Assumptions

    ASSUMPTIONS 2005 2006 2007 Gross Profit 63% 64% 64.5% Operating expense 38.5% 37% 36.5% Operating Income 24.5% 27% 28% ETR 21% 20% 20% Shares Outstanding 45M 46M 46.7M

  10. Slide 10: Post-Deal Capital Structure

    POST-DEAL CAPITAL STRUCTURE ($ in millions) Total Debt $770 Stockholders’ Equity $1106 Total Capitalization $1876 Total Debt/Capitalization 41%

  11. Slide 11: Cooper Companies Forward-Looking Statements

    Cooper Companies Forward-Looking Statements This document contains “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995. These include certain statements about the merger with Ocular Sciences, our capital resources, performance and results of operations. In

Cooper Companies — Merger or Acquisition (July 2004) on 6ix